Shanghai Kindly Medical Instruments Co., Ltd. announced that the first patient implantation of HanchorValve, a balloon-expandable transcatheter aortic valve replacement product with an anchoring structure developed by Shanghai Healing Medical Instruments Co., Ltd, a subsidiary of the Company, has been successfully completed by Zhongshan Hospital, Fudan University, which is also the first valve replacement operation that uses the balloon-expandable TAVR product with an anchoring structure to treat patient with severe aortic regurgitation in the world. HanchorValve is the first TAVR product that Healing Medical has self-owned intellectual property rights, which is able to achieve precise and autonomous localization by virtue of its unique design of anchoring structure. It is also the first balloon-expandable TAVR product in the world that can treat both severe aortic regurgitation and severe aortic stenosis by transfemoral approach. The success achieved in the first patient implantation of HanchorValve clinical trial marks the official launch of national multi-center clinical trial with Zhongshan Hospital, Fudan University as the major research center.